Measles-Related Vitamin A Searches Rise - Summary - MDSpire
Advertisement
Measles-Related Vitamin A Searches Rise
Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.
To examine the association between media statements promoting vitamin A as a treatment for measles and the increase in internet searches related to vitamin A and cod liver oil during the 2025 US measles outbreak.
Approach:
Study Design: A cross-sectional study using Google Search Trends to analyze daily US search activity for 'vitamin A' measles and 'cod liver' measles from January 1 to June 1, 2025.
Data Analysis: Utilized relative search fraction as a measure of public interest, calculated mean relative search fraction estimates and 95% confidence intervals (CIs), and performed interrupted time-series analysis with Bayesian segmented regression.
Key Findings:
Search interest for 'vitamin A' measles peaked at 44% on March 22, 2025.
Search interest for 'cod liver' measles peaked on March 5, 2025.
Vitamin A search interest was a mean 7.5 percentage points higher than counterfactual estimates after media coverage began.
Cod liver oil search interest was 1.3 percentage points higher than expected.
Interpretation:
The findings indicate an association between media statements and increased search interest in vitamin A and cod liver oil.
Limitations:
The study could not determine if increased search activity led to actual use of vitamin A or cod liver oil.
The analysis was limited to Google Search Trends data, reflecting search interest rather than broader public behavior or clinical outcomes.
No control search terms were reported in the analysis.
Conclusion:
The study highlights the correlation between media statements and public interest in vitamin A during a measles outbreak.
A posthoc analysis of a phase 2b trial found favorable changes in DNA methylation–based aging biomarkers among patients with human immunodeficiency virus–associated lipohypertrophy.